Eupraxia Pharmaceuticals (EPRX) Share-based Compensation (2023 - 2026)
Eupraxia Pharmaceuticals' Share-based Compensation came in at $3.03 million for Q2 2026, up 171.4% from $1.12 million a year earlier and up 34.6% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Eupraxia Pharmaceuticals reported Share-based Compensation of $11.43 million, up 175.7% year-over-year; for FY2025, it was $8.76 million, up 171.6% from FY2024.
- Share-based Compensation carries a three-year compound annual growth rate of 82.8% (FY2022 to FY2025).
- Going back by year, Share-based Compensation was $3.22 million in FY2024 (+128.2%), $1.41 million in FY2023 (-1.5%) and $1.43 million in FY2022.
- The five-year range for quarterly Share-based Compensation is $213,130 (Q1 2024) to $5.7 million (Q4 2025).
- Year-over-year, Share-based Compensation has increased for three consecutive quarters, with growth averaging 189.3% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2025 (growth of 600.7%), and the weakest in Q1 2024 (a decline of 32.9%).
- Business Quant data shows EPRX's Share-based Compensation at $2.25 million (Q1 2026), $5.7 million (Q4 2025) and $446,106 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 2.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.13 Mn |
| Jun 30, 2026 | 3.03 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 5.70 Mn |
| Sep 30, 2025 | 446,106.00 |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 507,246.00 |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 213,130.00 |
| Dec 31, 2023 | 309,844.00 |
| Sep 30, 2023 | 358,875.00 |
| Jun 30, 2023 | 426,118.00 |
| Mar 31, 2023 | 317,420.00 |
API Access
Eupraxia Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();